AU778834B2 - Fatty acid analogs for diagnosis of coronary artery disease - Google Patents
Fatty acid analogs for diagnosis of coronary artery disease Download PDFInfo
- Publication number
- AU778834B2 AU778834B2 AU42433/00A AU4243300A AU778834B2 AU 778834 B2 AU778834 B2 AU 778834B2 AU 42433/00 A AU42433/00 A AU 42433/00A AU 4243300 A AU4243300 A AU 4243300A AU 778834 B2 AU778834 B2 AU 778834B2
- Authority
- AU
- Australia
- Prior art keywords
- fatty acid
- radiolabeled fatty
- radioisotope
- radiolabeled
- sum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12929899P | 1999-04-14 | 1999-04-14 | |
| US60/129298 | 1999-04-14 | ||
| PCT/US2000/010096 WO2000061196A2 (en) | 1999-04-14 | 2000-04-14 | Fatty acid analogs for diagnosis of coronary artery disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4243300A AU4243300A (en) | 2000-11-14 |
| AU778834B2 true AU778834B2 (en) | 2004-12-23 |
Family
ID=22439338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU42433/00A Ceased AU778834B2 (en) | 1999-04-14 | 2000-04-14 | Fatty acid analogs for diagnosis of coronary artery disease |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6437103B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1173226B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003517457A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE337020T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU778834B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2366789C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60030270T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2269131T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000061196A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2374743T3 (es) * | 1995-12-01 | 2012-02-21 | Molecular Insight Pharmaceuticals, Inc. | Estereoisómeros de análogos de ácidos grasos para imagen de diagnóstico. |
| US7381399B2 (en) * | 2002-03-11 | 2008-06-03 | Molecular Insight Pharmaceuticals, Inc. | Technetium-dipyridine complexes, and methods of use thereof |
| AU2003226169C1 (en) * | 2002-04-01 | 2010-01-07 | Molecular Insight Pharmaceuticals, Inc. | Pendant fatty acid imaging agents |
| EP1622602B1 (en) * | 2003-04-17 | 2008-08-20 | The General Hospital Corporation | Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| KR100533674B1 (ko) * | 2004-02-25 | 2005-12-06 | 한국원자력연구소 | 수소화붕소 교환수지를 이용한 레늄 착물의 제조방법 |
| US20080226555A1 (en) * | 2005-06-08 | 2008-09-18 | Bengt Langstrom | Method for the Use of [11C] Carbon Monoxide in Labeling Synthesis of 11C-Labelled Esters and Acids by Sensitized Photo-Induced Free Radical |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4524059A (en) * | 1983-01-28 | 1985-06-18 | The General Hospital Corporation | Fatty acid analogs |
| US4615876A (en) * | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
| US4746505A (en) * | 1985-04-26 | 1988-05-24 | President And Fellows Of Harvard College | Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands |
| ES2374743T3 (es) * | 1995-12-01 | 2012-02-21 | Molecular Insight Pharmaceuticals, Inc. | Estereoisómeros de análogos de ácidos grasos para imagen de diagnóstico. |
-
2000
- 2000-04-14 WO PCT/US2000/010096 patent/WO2000061196A2/en not_active Ceased
- 2000-04-14 AU AU42433/00A patent/AU778834B2/en not_active Ceased
- 2000-04-14 CA CA2366789A patent/CA2366789C/en not_active Expired - Fee Related
- 2000-04-14 JP JP2000610528A patent/JP2003517457A/ja active Pending
- 2000-04-14 DE DE60030270T patent/DE60030270T2/de not_active Expired - Lifetime
- 2000-04-14 AT AT00922209T patent/ATE337020T1/de not_active IP Right Cessation
- 2000-04-14 US US09/549,732 patent/US6437103B1/en not_active Expired - Fee Related
- 2000-04-14 ES ES00922209T patent/ES2269131T3/es not_active Expired - Lifetime
- 2000-04-14 EP EP00922209A patent/EP1173226B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60030270D1 (de) | 2006-10-05 |
| ATE337020T1 (de) | 2006-09-15 |
| JP2003517457A (ja) | 2003-05-27 |
| AU4243300A (en) | 2000-11-14 |
| CA2366789A1 (en) | 2000-10-19 |
| US6437103B1 (en) | 2002-08-20 |
| WO2000061196A2 (en) | 2000-10-19 |
| EP1173226A2 (en) | 2002-01-23 |
| ES2269131T3 (es) | 2007-04-01 |
| CA2366789C (en) | 2010-09-28 |
| WO2000061196A3 (en) | 2001-07-26 |
| DE60030270T2 (de) | 2007-08-30 |
| EP1173226B1 (en) | 2006-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4925650A (en) | Technetium -99m complex for examining the renal function | |
| AU2020262961B2 (en) | Prostate-specific membrane antigen (PSMA) inhibitors as diagnostic and radionuclide therapeutic agents | |
| Volkert et al. | Technetium-99m chelates as radiopharmaceuticals | |
| Kung | New technetium 99m-labeled brain perfusion imaging agents | |
| Oya et al. | Small and neutral TcvO BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents | |
| US5986074A (en) | Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof | |
| AU2004210208B2 (en) | Diagnostic imaging agents with MMP inhibitory activity | |
| Choi et al. | An improved kit formulation of a dopamine transporter imaging agent:[Tc-99m] TRODAT-1 | |
| NZ263794A (en) | Compound suitable for forming tc and re chelates, radiopharmaceutical compositions thereof | |
| JPH06502640A (ja) | テクネチウム−99m錯化合物の放射性医薬としての使用 | |
| EP1173226B1 (en) | Fatty acid analogs for diagnosis of coronary artery disease | |
| JP4338394B2 (ja) | テクネチウム−99m窒化物ヘテロ錯体を含有する放射性画像診断剤 | |
| US5876693A (en) | Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals | |
| JPH06501450A (ja) | シクロペンタジエニルカルボニル―99mTc錯体、その製造法および診断学への該化合物の使用 | |
| EP0949265B1 (en) | Radioactive transition metal nitride hetero-complex | |
| Jones Jr et al. | Synthesis and biodistribution of a new 99mtechnetium fatty acid | |
| Ohmomo et al. | New conformationally restricted technetium-99m N2S2 complexes as myocardial perfusion imaging agents | |
| Kothari et al. | Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP2) chelate | |
| Cazzola et al. | Labeling of fatty acid ligands with the strong electrophilic metal fragment [99mTc (N)(PNP)] 2+(PNP= diphosphane ligand) | |
| Zhuang et al. | Neutral and stereospecific Tc-99m complexes:[99mTc] N-benzyl-3, 4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT) | |
| Blau | Radiotracers for functional brain imaging | |
| WO2023100852A1 (ja) | 安定化放射性医薬組成物 | |
| Eckelman et al. | Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution | |
| JP2564459B2 (ja) | 放射性医薬品調製用キャリヤー | |
| US20040087567A1 (en) | Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |